Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Facilitating Participation in Clinical Trials and Advocating for Patients Throughout the Trial Life Cycle with Robert Maxwell ClinConnect TRANSCRIPT
Download PDFFeb 6, 2024
Robert Maxwell, Founder and CEO of ClinConnect, has created a platform that simplifies the process of patients finding clinical trials, shortens enrollment times, and focuses on providing support to ensure patient retention in the trials. The platform works in collaboration with sponsors, healthcare providers, hospitals, and other stakeholders to streamline communication and more quickly identify qualified clinical trial participants from a broader universe.
Robert explains, "We make the process of not only finding the trial very, very simple, but we also shorten the enrollment times, which in the case of acute disease is distinctly important. But generally speaking, it's usually more advantageous to get into a trial more quickly than waiting unnecessarily. And so, while we don't claim to solve all clinical trial recruitment issues, we've found that our patients generally see about a 60% to 70% reduction in enrollment time by working with us and letting us be their advocate through the enrollment process."
"On the flip side, with pharmaceutical companies who are sponsoring these trials or running them directly, 70% of trials don't meet their recruitment targets. And that's profoundly problematic for them."
"So, we do not just work with the patient to get them into the trial. We will continue to advocate for them. And as we use the term, we'll hold their hand through the entire trial process. Then, we even have some post-trial services and some work we do with them after the trial. So we have found that because we don't just work with them in one kind of component of the life cycle of the trial, our retention rates are much higher as well. "
#ClinConnect #ClinicalTrials #TrialRetention #TrialRecruitment #DigitalHealth #PatientAdvocacy
